Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

First-trimester screening.

David A Nyberg1, Jon Hyett, Jo-Ann Johnson

  • 1Fetal and Women's Center of Arizona, 9440 E. Ironwood Square Drive, Scottsdale, AZ 85258, USA. nyberg@u.washington.edu

Radiologic Clinics of North America
|December 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reproductive Carrier Screening Detects Early Actionable Metabolic Conditions.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

Expanding First-Trimester Preterm Preeclampsia Screening With Placental Growth Factor Testing.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC·2026
Same author

Cell-Based and Cell-Free Non-Invasive Prenatal Analysis of Preeclampsia: An Updated Review of Liquid Biopsy.

Biomedicines·2026
Same author

Impact of a Routine Third Trimester Ultrasound Policy on Obstetric, Neonatal and Service Delivery Outcomes in an Australian Tertiary Centre.

The Australian & New Zealand journal of obstetrics & gynaecology·2026
Same author

Testing for hereditary cancer genes in men: a missed opportunity for cancer prevention.

Frontiers in oncology·2026
Same author

Disparities in genetic testing: Evaluation of reproductive carrier screening in the United States.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same journal

Orbital Imaging.

Radiologic clinics of North America·2026
Same journal

Imaging, Management, and Treatment of Orbital Trauma.

Radiologic clinics of North America·2026
Same journal

Imaging Findings after Multidisciplinary Treatment for Orbital and Ocular Adnexal Cancers.

Radiologic clinics of North America·2026
Same journal

Orbital Tumors: What the Radiologist Needs to Know from the Orbital Surgeon's Perspective.

Radiologic clinics of North America·2026
Same journal

Multidisciplinary Management of Tumors of the Orbit.

Radiologic clinics of North America·2026
Same journal

Skull Base, Bone, Pituitary-Regions around Orbit that Affect Vision.

Radiologic clinics of North America·2026
See all related articles

Advances in fetal screening, especially for trisomy 21, improve risk assessment for pregnant patients. This leads to reduced invasive procedures and better management of fetal chromosome abnormalities.

Area of Science:

  • Prenatal diagnostics
  • Fetal medicine
  • Genetics

Background:

  • Screening for fetal chromosome abnormalities has advanced significantly.
  • Improved screening identifies high-risk pregnancies, including those over 35, with greater accuracy.

Purpose of the Study:

  • To evaluate the impact of advanced screening on managing fetal chromosome abnormalities.
  • To assess changes in amniocentesis rates and resource allocation.
  • To explore the trend towards first-trimester detection of structural defects.

Main Methods:

  • Review of advancements in screening technologies for fetal chromosome abnormalities.
  • Analysis of risk stratification for different maternal age groups.
  • Evaluation of procedural-related fetal losses and resource utilization.

Related Experiment Videos

  • Assessment of first-trimester ultrasound for detecting structural defects.

    • Main Results:

    • Better screening lowers the perceived risk for older, high-risk patients compared to younger, unscreened individuals.
    • Amniocentesis rates have decreased for older patients, while screening is more accessible for younger ones.
    • Reduced procedural risks for normal fetuses and optimized resource allocation are observed.
    • First-trimester surveys are increasingly used for early detection and reassurance.

    Conclusions:

    • Modern fetal screening enhances diagnostic accuracy for chromosome abnormalities like trisomy 21.
    • Screening allows for personalized risk assessment, reducing unnecessary invasive procedures.
    • Early detection via first-trimester screening improves fetal anomaly management and patient care.